CEO and President
Padideh defines herself as an artist, entrepreneur and a scientist. She is an established figure in geometric modelling and holds a PhD in Biological Physics from the Royal Institute of Technology in Stockholm.
Darmiyan is using fully-automated proprietary software to produce maps that aim to reduce the cost and time it takes to test for early-onset Alzheimer’s disease – up to 15 years before symptoms start. The company has tested 3,000 patients so far. Even before submitting itself for FDA approval, the company has signed up a $1 million contract.
Currently, there are 26 million Americans who should be tested, and each test costs $500, which means a potential $13 billion market for the company. Padideh is an adjunct professor at NYU and she teaches classical Persian music in her free time (i.e. if she gets any), which she claims has helped maintain her sanity while working as the CEO of Darmiyan.
Latest TweetsTweets by TwitterDev